Inogen Appoints New CFO, Michael T. Lio
Ticker: INGN · Form: 8-K · Filed: Jul 3, 2024 · CIK: 1294133
| Field | Detail |
|---|---|
| Company | Inogen Inc (INGN) |
| Form Type | 8-K |
| Filed Date | Jul 3, 2024 |
| Risk Level | medium |
| Pages | 6 |
| Reading Time | 7 min |
| Key Dollar Amounts | $0.001, $420,000, $100,000, $500,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: management-change, cfo-appointment
Related Tickers: INGN
TL;DR
Inogen just swapped CFOs, Lio is in, Kinder is out.
AI Summary
Inogen Inc. announced on July 2, 2024, the appointment of Michael T. Lio as its new Chief Financial Officer, effective immediately. Lio previously served as the company's Senior Vice President, Finance and Chief Accounting Officer. The company also announced the departure of its former CFO, Matthew C. Kinder, on the same date.
Why It Matters
A change in CFO can signal shifts in financial strategy or management focus, impacting investor confidence and the company's financial reporting.
Risk Assessment
Risk Level: medium — Changes in key financial leadership can introduce uncertainty regarding future financial strategy and performance.
Key Players & Entities
- Inogen Inc. (company) — The company making the announcement.
- Michael T. Lio (person) — Newly appointed Chief Financial Officer.
- Matthew C. Kinder (person) — Departing Chief Financial Officer.
- July 02, 2024 (date) — Effective date of the CFO change.
FAQ
Who has been appointed as the new Chief Financial Officer of Inogen Inc.?
Michael T. Lio has been appointed as the new Chief Financial Officer of Inogen Inc.
When was the appointment of the new CFO effective?
The appointment of Michael T. Lio as CFO was effective July 02, 2024.
Who previously held the position of CFO at Inogen Inc.?
Matthew C. Kinder previously held the position of CFO at Inogen Inc.
What was Michael T. Lio's previous role at Inogen Inc.?
Michael T. Lio's previous role at Inogen Inc. was Senior Vice President, Finance and Chief Accounting Officer.
What is Inogen Inc.'s principal executive office address?
Inogen Inc.'s principal executive office is located at 859 Ward Drive, Goleta, California, 93111.
Filing Stats: 1,742 words · 7 min read · ~6 pages · Grade level 13.1 · Accepted 2024-07-03 16:15:10
Key Financial Figures
- $0.001 — nge on which registered Common Stock, $0.001 par value INGN The Nasdaq Stock Mar
- $420,000 — h will receive an annual base salary of $420,000 and a target annual performance bonus o
- $100,000 — so provides for a cash sign-on bonus of $100,000, which is repayable on a pro-rata basis
- $500,000 — employment agreement also provides for $500,000 of equity awards in the form of restric
Filing Documents
- ingn-20240702.htm (8-K) — 53KB
- ingn-ex10_1.htm (EX-10.1) — 172KB
- ingn-ex99_1.htm (EX-99.1) — 15KB
- img132417817_0.jpg (GRAPHIC) — 4KB
- img132417817_1.jpg (GRAPHIC) — 3KB
- 0000950170-24-081526.txt ( ) — 394KB
- ingn-20240702.xsd (EX-101.SCH) — 24KB
- ingn-20240702_htm.xml (XML) — 5KB
01. Regulation FD Disclosure
Item 7.01. Regulation FD Disclosure On July 3, 2024, the Company issued a press release announcing the appointment and transition described in this Current Report on Form 8-K. A copy of the press release is furnished herewith as Exhibit 99.1. The information set forth under this Item 7.01, including Exhibit 99.1, shall not be deemed "filed" for purposes of Section 18 of the Exchange Act, or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any general incorporation language in such filing, unless expressly incorporated by specific reference in such filing.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits (d) Exhibits Exhibit Description 10.1 Employment and Severance Agreement by and between the Company and Kevin P. Smith dated effective as July 22, 2024 99.1 Press Release dated July 3, 2024 104 The cover page of this Current Report on Form 8-K, formatted in Inline XBRL.
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. INOGEN, INC. Date: July 3, 2024 By: /s/ Michael Bourque Michael Bourque Executive Vice President Chief Financial Officer Treasurer (Principal Accounting and Financial Officer)